AFJOG

REVIEW ¤ ¤ ¢ © ¢ ¬ ¾ µ ¹ · ¥ ¥ ¥ ¤ ¥ ¨ ¥ ¢ § ± ¤ ¬ § © · ½ ¥ ° · ¬ The authors have requested the following erratum be made to the Cervical Cancer Screening Guidelines published in the first edition of AFJOG. The erratum has been incorporated into the online version of the guidelinesreference 1. The affiliation of Dr Nomonde Mbatani is as follows: Department of Obstetrics and Gynaecology, University of Cape Town and Groote Schuur Hospital, SAMRC Gynaecological Cancer Research Centre, Cape Town, South Africa 2. Under the heading “Triage Tests” the second paragraph is replaced with the following paragraph: In these guidelines the recommendation is to selective triage of those who test positive for “other high-risk HPV” by immediately referring to treatment all HIV negative women who are 40 years and older, as this group has a significantly higher risk for disease and the risk of overtreatment is less. On the other hand, women either younger than 40 years, or HIV-positive are triaged by reflex cytology in the laboratory, and treated only if their cytology shows HSIL or more. If the triage test is negative, they return for screening in one year. 3. In the flow diagram the word “ and has been removed Erratum All women 25 years and older: Primary HPV screening test every 5 to 10 years N gative Next screening in 5 to 10 years HPV16,18 POS (Add 45 if included in result) Treat directly (can do colposcopy with biopsy first) 40y+ and HIV NEG Treat directly < HSIL: Follow-up HPV test in 12 months Any HPV POS: Colposcopy to consider treatment <40y or HIV POS: Reflex cytology ASC-H/HSIL: Treat Follow-up HPV test in 12 months Follow-up HPV test in 12 months Other high risk HPV POS African Journal of Obstetrics and Gynaecology | Volume 1 | Issue 2 | 2023 | 19